These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3381910)

  • 41. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice.
    Hirosue Y; Inui A; Teranishi A; Miura M; Nakajima M; Okita M; Nakajima Y; Himori N; Baba S; Kasuga M
    Am J Physiol; 1993 Sep; 265(3 Pt 2):R481-6. PubMed ID: 8214137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholecystokinin-58 is more potent in inhibiting food intake than cholecystokinin-8 in rats.
    Glatzle J; Raybould HE; Kueper MA; Reeve JR; Zittel TT
    Nutr Neurosci; 2008 Apr; 11(2):69-74. PubMed ID: 18510806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The taste reactivity test. II. Mimetic responses to gustatory stimuli in chronic thalamic and chronic decerebrate rats.
    Grill HJ; Norgren R
    Brain Res; 1978 Mar; 143(2):281-97. PubMed ID: 630410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neural substrates for reflex salivation induced by taste, mechanical, and thermal stimulation of the oral region in decerebrate rats.
    Matsuo R; Yamamoto T; Yoshitaka K; Morimoto T
    Jpn J Physiol; 1989; 39(3):349-57. PubMed ID: 2796017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of cholecystokinin octapeptide analogues on food intake in the dog.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Oimomi M; Baba S
    Am J Physiol; 1989 Oct; 257(4 Pt 2):R946-51. PubMed ID: 2802006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intake inhibition by NPY and CCK-8: A challenge of the notion of NPY as an "Orexigen".
    Ammar AA; Nergårdh R; Fredholm BB; Brodin U; Södersten P
    Behav Brain Res; 2005 Jun; 161(1):82-7. PubMed ID: 15904713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholecystokinin octapeptide decreases food intake in white-crowned sparrows.
    Richardson RD; Boswell T; Weatherford SC; Wingfield JC; Woods SC
    Am J Physiol; 1993 May; 264(5 Pt 2):R852-6. PubMed ID: 8498593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interpretation of sham feeding data: curve-shift studies.
    Weingarten HP; Duong A; Elston D
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1009-16. PubMed ID: 8897994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gastric emptying changes are neither necessary nor sufficient for CCK-induced satiety.
    Conover KL; Collins SM; Weingarten HP
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R56-62. PubMed ID: 2912226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats.
    Weller A; Blass EM
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R901-7. PubMed ID: 3202224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Respiratory actions induced by cholecystokinin at the brainstem level.
    Hurlé MA; Dierssen MM; Morin-Surun MP; Oceja C; Flórez J
    Peptides; 1988; 9(4):809-15. PubMed ID: 3226957
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats.
    Lukaszewski L; Praissman M
    Am J Physiol; 1988 Jan; 254(1 Pt 2):R17-22. PubMed ID: 3337268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of peripherally administered cholecystokinin-8 and secretin on feeding/drinking and oxytocin-mRFP1 fluorescence in transgenic rats.
    Motojima Y; Kawasaki M; Matsuura T; Saito R; Yoshimura M; Hashimoto H; Ueno H; Maruyama T; Suzuki H; Ohnishi H; Sakai A; Ueta Y
    Neurosci Res; 2016 Aug; 109():63-9. PubMed ID: 26919961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cholecystokinin on food intake at different stages of the estrous cycle in female rats.
    Huang YS; Doi R; Chowdhury P; Pasley JN; Nishikawa M; Huang TJ; Rayford PL
    J Assoc Acad Minor Phys; 1993; 4(2):56-8. PubMed ID: 8490287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
    Millington WR; Mueller GP; Lavigne GJ
    J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duodenal sucrose and glucose infusions enhance suppression by cholecystokinin of sham feeding.
    Cox JE
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R466-71. PubMed ID: 8141404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic administration of cholecystokinin (CCK) inhibits operant water intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Proc Biol Sci; 1996 Apr; 263(1369):491-6. PubMed ID: 8637930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
    Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.